REGENXBIO
RGNX
$16.19
Share price
0.81%
Change (1 day)
-13.19%
Change (1 year)
Categories
REGENXBIO (RGNX) - Cash on Hand
Cash on Hand as of December 2023 : $0.27 B
According to REGENXBIO's latest financial reports the company has $0.27 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
REGENXBIO - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.27 B | -24.51% |
| 2022-12-31 | $0.36 B | -20.29% |
| 2021-12-31 | $0.45 B | -3.85% |
| 2020-12-31 | $0.47 B | 60.61% |
| 2019-12-31 | $0.29 B | -7.37% |
| 2018-12-31 | $0.31 B | 98.88% |
| 2017-12-31 | $0.16 B | 79.53% |
| 2016-12-31 | $89.55 M | -21.54% |
| 2015-12-31 | $0.11 B | 10082.07% |
| 2014-12-31 | $1.12 M | 0.18% |
| 2013-12-31 | $1.11 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -24.37% | 🇺🇸 USA |